Real world data and FDA: Drugmakers seek more clarity on registry guidance

As the FDA crafts a new series of guidance documents on how biopharma companies can use real-world data, including patient registries, to help supplement their applications, pharma companies and industry group PhRMA are calling for more details and more consistency from the agency.

March 07, 2022